Kenvue Interest Paid remained flat by 0.0% to $110.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.2%, from $109.75M to $110.00M. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $224.00M | $439.00M | $440.00M |
| YoY Change | — | — | — | +96.0% | +0.2% |